Sequence alterations using homologous recombination

• US 5,948,653 A
• Filed: 08/13/1997
• Issued: 09/07/1999
• Est. Priority Date: 03/21/1997
• Status: Expired due to Fees

• Current Assignee: SRI International, Inc.
• Original Assignee: SRI International, Inc.
• Inventors: Pati, Sushma, Zarling, David A.
• Primary Examiner(s): Degen, Nancy
• Assistant Examiner(s): SCHWARTZMAN, ROBERT A
• Application Number:
  US08/910,367
• Time in Patent Office: 755 Days
• Field of Search: 435/172.1, 435/172.3, 435/91.1, 530/350, 536/23.1
• US Class Current: 435/6.14
• CPC Class Codes: A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
• CPC Class Codes: C12N 15/102 Mutagenizing nucleic acids
• CPC Class Codes: C12N 15/1027 by DNA shuffling, e.g. RSR, STEP, RPR
• CPC Class Codes: C12N 15/90 Stable introduction of foreign DNA into chromosome
• CPC Class Codes: C12N 15/907 in mammalian cells

Abstract

The invention relates to methods for targeting an exogenous polynucleotide or exogenous complementary polynucleotide pair to a predetermined endogenous DNA target sequence in a target cell by homologous pairing, particularly for altering an endogenous DNA sequence, such as a chromosomal DNA sequence, typically by targeted homologous recombination. In certain embodiments, the invention relates to methods for targeting an exogenous polynucleotide having a linked chemical substituent to a predetermined endogenous DNA sequence in a metabolically active target cell, generating a DNA sequence-specific targeting of one or more chemical substituents in an intact nucleus of a metabolically active target cell, generally for purposes of altering a predetermined endogenous DNA sequence in the cell. The invention also relates to compositions that contain exogenous targeting polynucleotides, complementary pairs of exogenous targeting polynucleotides, chemical substituents of such polynucleotides, and recombinase proteins used in the methods of the invention.

Claims

1. A method for targeting and modifying, by homologous recombination, a pre-selected target nucleic acid sequence in an extrachromosomal sequence of a procaryotic cell, said method comprising;

a) adding to said extrachromosmal sequence at least one recombinase and at least two single-stranded targeting polynucleotides each of which are substantially complementary to each other and comprise a homology clamp that substantially corresponds to or is substantially complementary to a preselected target nucleic acid sequence to form a modified extrachromosomal sequence, wherein the target nucleic acid sequence is modified;

b) removing said recombinase; and

c) introducing said modified extrachromosomal sequence into a procaryotic cell.

2. A method according to claim 1 further comprising identifying said procaryotic cell having a targeted nucleic acid sequence modification at a preselected target nucleic acid sequence.

3. A method according to claim 1 wherein said targeting polynucleotides are coated with said recombinase.

4. A method according to claim 1, wherein said recombinase is a species of prokaryotic recombinase.

5. A method according to claim 1, wherein said recombinase is a species of eukaryotic recombinase.

6. A method according to claim 1, wherein at least one of said targeting polynucleotides is conjugated to a cell-uptake component.

7. A method according to claim 1, wherein the targeted sequence modification comprises a deletion of at least one nucleotide.

8. A method according to claim 1, wherein the targeted sequence modification comprises the addition of at least one nucleotide.

9. A method according to claim 1, wherein said single stranded targeting polynucleotides comprise an internal homology clamp.

10. A method according to claim 1, wherein the targeted sequence modification comprises the substitution of at least one nucleotide.

11. A method according to claim 1, wherein the targeting polynucleotides are introduced into the target cell by a method selected from the group consisting of:

microinjection, electroporation, laser poration, biolistics, and contacting of the cell with a lipid-protein-targeting polynucleotide complex.

12. A method according to claim 1, wherein each targeting polynucleotide comprises a homology clamp that is less than 1200 nucleotides long.

13. A method according to claim 1, wherein the targeting polynucleotides are less than 1200 nucleotides long.

14. A method according to claim 1, wherein the targeted sequence modification adds a gene to said cell.

15. A method according to claim 1, wherein at least one of said complementary single stranded targeting polynucleotides further comprises a chemical substituent.

16. A method according to claim 1, wherein the targeted sequence modification deletes a gene from said cell.

17. A method according to claim 4, wherein said prokaryotic recombinase is a species of prokaryotic recA protein.

18. A method according to claim 5, wherein said recombinase is a Rad51 recombinase.

19. A method according to claim 5, wherein said eukaryotic recombinase is a complex of recombinase proteins.

20. A method according to claim 6, wherein said cell-uptake component is conjugated to at least one of said targeting polynucleotides by noncovalent binding.

21. A method according to claim 6, wherein the cell-uptake component comprises a protein-lipid complex.

22. A method according to claim 7, wherein the targeted sequence modification comprises a plurality of deletions.

23. A method according to claim 8, wherein the targeted sequence modification comprises a plurality of additions.

24. A method according to claim 10, wherein the targeted sequence modification comprises a plurality of substitutions.

25. A method according to claim 15, wherein said chemical substituent is covalently attached to said targeting polynucleotide.

26. A method according to claim 17, wherein said recA protein species is E. coli recA.

27. A method of generating a pool of variant nucleic acid sequences of a pre-selected target nucleic acid sequence in an extrachromosomal sequence, said method comprising adding to said extrachromosomal sequence at least one recombinase and a plurality of pairs of single-stranded targeting polynucleotides which are substantially complementary to each other and each comprising a homology clamp that substantially corresponds to or is substantially complementary to a preselected target nucleic acid sequence, said plurality of pairs comprising a library of mismatches between said targeting polynucleotide and said target nucleic acid sequence, to form a library of altered extrachromosomal sequences.

28. A method according to claim 27 further comprising transforming said pool of altered sequences into a population of cells.

29. A method according to claim 28 wherein said cells are procaryotic.

30. A method according to claim 28 or wherein said cells are eukaryotic.

34. A method according to claim 28 or 31 further comprising screening said population for a desired phenotype.

31. A method of generating a cellular library comprising variant nucleic acid sequences of a pre-selected target nucleic acid sequence in an extrachromosomal sequence of a target cell, said method comprising:

a) adding to said extrachromosomal sequence at least one recombinase and a plurality of pairs of single-stranded targeting polynucleotides which are substantially complementary to each other and each comprising a homology clamp that substantially corresponds to or is substantially complementary to a preselected target nucleic acid sequence, said plurality of pairs comprising a library of mismatches between said targeting polynucleotide and said target nucleic acid sequence, to form a plurality of altered extrachromosomal sequences;

b) removing said recombinase; and

c) introducing said altered sequences into a population of target cells to form said library of variant nucleic acid sequences.

32. A method according to claim 31, wherein said target cells are procaryotic.

33. A method according to claim 31, wherein said target cells are eukaryotic.

35. A composition comprising at least one recombinase and a variant library comprising a plurality of pairs of single stranded targeting polynucleotides which are substantially complementary to each other and each comprising a homology clamp that substantially corresponds to or is substantially complementary to a preselected target nucleic acid sequence, said plurality of pairs comprising a library of mismatches between said targeting polynucleotide and said target nucleic acid sequence.

36. A composition according to claim 35 wherein said targeting polynucleotides are coated with recombinase.

37. A composition according to claim 35 wherein said recombinase is a species of prokaryotic recombinase.

38. A composition according to claim 35 wherein said recombinase is a species of prokaryotic recA recombinase.

39. A kit comprising the composition of claim 35 and at least one reagent.

40. A composition according to claim 38 wherein said recA recombinase is E. coli recA.